1. Introduction
Endophytic fungi live within plant tissue without causing apparent injury or symptoms to the host plant [1]. Some of these endophytes provide protection to their host plant from tissue-invading pathogens [2]. They are known to produce secondary metabolites with pharmacological importance such as antibiotic, antiviral, antidiabetic, and antiinflammatory compounds [3–6]. In some cases, endophytes in plants have been found to produce similar compounds as host plant [7].
The genus Cinnamomum belongs to the family Lauraceae. There are 21 species of Cinnamomum in Peninsular Malaysia [8]. Plants of this genus such as C. zelyanicum and C. cassia have been extensively used as antiseptic agents [9–11] and to treat bronchitis, cold, and sinus in herbal therapy [12]. Products of the plant such as cinnamon powder have been reported to possess minor antibacterial and antifungal activities on the skin [13]. Essential oil extract of C. mollissimum leaf has been found to have broad antifungal activity [14]. Recent findings describe the anticancer property of a constituent from C. kotoense leaf. This explains why plants of these species are also used to treat warts and certain cancerous tumours [15].
As plants of Cinnamomum species have medicinal value, endophytic fungi from C. mollissimum were isolated and screened for antimicrobial activity. One endophytic fungal isolate was then selected to further evaluate its biological activity and to identify the bioactive compound which gives rise to the activity.
2. Methods
2.1. Isolation of Endophytic Fungi
Endophytic fungi were isolated from the plant C. mollissimum which was sampled at Universiti Kebangsaan Malaysia Forest Reserve, Selangor, Malaysia. The plant specimen voucher number 955 was deposited in the herbarium of Universiti Kebangsaan Malaysia. Plant leaf and stem pieces were surface sterilized [16] and cultured on potato dextrose agar and water agar to isolate endophytic fungi.
2.2. Preliminary Screening for Antimicrobial Activity
All fungal isolates recovered from the plant were screened for antimicrobial activity by using a modified agar plate-based assay [17]. In this assay, the fungal isolate was grown on potato dextrose agar (PDA) at 27°C for 14 days. The target organisms were streaked radial to the original growth of the fungal isolate in the centre of the plate. The target organisms comprising of bacterial and fungal pathogens were Staphylococcus aureus, Bacillus subtilis, Escherichia coli, Pseudomonas aeruginosa, Candida albicans, Aspergillus niger, Trichoderma viridae, Fusarium solani, and Aspergillus fumigatus. Antimicrobial activity was determined as growth inhibition of the target organism.
2.3. Extraction of Fungal Metabolites
One fungal isolate, coded as CB 007 (WA), which showed antimicrobial activity was selected for further evaluation. The fungus was cultured in 200 mL of potato dextrose broth with shaking mode at 140 rotations per minute, for two weeks at 27°C. The culture broth and mycelia were separated by filtration where the broth was extracted with an equal amount of ethyl acetate overnight. The fresh solvent extract was concentrated with a rotary evaporator to obtain a crude extract.
2.4. Fractionation of Crude Extract
An aliquot of the crude extract (250 μg) was analyzed by reverse phase C18 high-performance liquid chromatography (HPLC) using the following gradient solvent system: 2 minutes (min) at 10% acetonitrile (ACN)/miliQ water (H2O); a linear gradient to 75% ACN/H2O over 12 min; isocratic at 75% for another 10 min; a linear gradient for 2 min to 100% ACN, isocratic at 100% ACN for 4 min then returned to 10% ACN/H2O over 2 min and reequilibrated for 8 min; with a flow rate 1 mL/min. The cycle lasted for 40 min, and the eluant was collected from 2.92 min to 24.92 min into 96-well polystyrene microtitre plates. A total of 88 fractions were collected, each fraction containing 250 μL of sample. HPLC was performed on a Dionex system equipped with an ISCO Foxy Jr. sample collector using a reversed phase analytical column (Phenomenex Prodigy C18, 4.6 × 250 mm, 5 μm) with photodiode array and evaporative light scattering detection (Alltech).
2.5. Cytotoxicity Assay
The cytotoxicity assay was carried out on HPLC fractions according to methods previously described [18]. A total of 88 fractions in a microtitre plate were collected from HPLC analysis. Preparation of a daughter plate was made by transferring 50 μL of extract fraction from each well of the master plate into another microtitre plate. The solvent was evaporated from the daughter plate by using a centrifugal evaporator machine before analysis for cytotoxicity against P388 murine leukaemia cells. For the P388 cytotoxicity assay, the following medium was used: β-Methoxyethoxymethyl, fetal calf serum (10%), penicillin (266 μg/mL), streptomycin (132 μg/mL), L-glutamine (2 mM), NaHCO3 (2.2 g/L), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (7.4 mM). The plate was incubated at 36°C for 3 days. After that, 20 μL of thiazolyl blue tetrazolium (MTT) solution (3.8 mg/mL in phosphate buffered saline) was added to every well and the plate was incubated for 4 hours at 36°C. The formazon product was dissolved in hydrochloric acid in isopropanol (170 μL, 0.08 M). Cell viability was determined by measuring the absorbance of every well at 540 nm. The absorbance of cell free control and the analyte free cell control was taken as 0% and 100% growth reference, respectively.
2.6. Antimicrobial Assay
A microtiter plate with HPLC fractions was prepared in the same way as for the P388 cytotoxicity assay. After evaporation of solvent in the microtitre plate, each well was added with 5% v/v methanol in water (10 μL), suspension of test organisms (40 μL; 5 × 105 colony forming unit (CFU)/mL for B. subtilis and 2.5 × 103 CFU/mL for A. niger and A. fumigatus), and medium (50 μL; RPMI-1640 for A. niger, A. fumigates, and Mueller Hinton broth for B. subtilis). After incubation (27°C; 48 hours for A. niger, A. fumigatus and 37°C; 24 hours for B. subtilis), an MTT solution (20 μL; 5 mg/mL) was added to all wells and further incubated (27°C; 4 hours). Subsequent to incubation, the formazon product was dissolved in dimethyl sulfoxide (100 μL). Cell viability percentage was determined by measuring the absorbance of every well at 540 nm and subtracting the absorbance of cell free control. The absorbance of cell free control (solvent solution + medium) and the analyte free cell control (solvent solution + test organisms in medium) was taken as 0% and 100% growth reference, respectively. Cell growth inhibition was calculated as 100%—cell viability %.
2.7. Isolation of Bioactive Compound
Following determination of cytotoxic and antimicrobial activities of HPLC fractions, one bioactive fraction was selected for compound isolation. The active compound in this fraction as determined by its UV profile was collected via HPLC method using the same system as for the fractionation of crude extract. The active compound was collected manually in vials using its retention time and UV profile as a reference. This process was repeated up to ten times to obtain sufficient amount of the compound for structure elucidation. The sample was concentrated by blowing nitrogen gas onto the sample placed on a heating block set at approximately 30°C.
2.8. Structure Elucidation of the Bioactive Compound
NMR and mass spectrometry experiments were carried out on the bioactive compound. The NMR experiments, hydrogen 1 NMR, correlation spectroscopy, total correlation spectroscopy, heteronuclear single quantum coherence, heteronuclear multiple bond correlation, were recorded on a Varian INOVA 500 spectrometer at 23°C, operating at 500 MHz at 23°C, using a Capillary probe. Meanwhile, high resolution electrospray lonisation mass spectra (HRESIMS) were obtained on a Micromass liquid chromatography time-of-flight mass spectrometer.
The bioactive compound formed crystals when solvent from the compound sample was evaporated overnight using nitrogen gas at 8 to 10°C. X-ray crystallography of these crystals was carried out with a Bruker APEXII CCD area detector using graphite monochromised Mo Kα (γ = 0.71073 Å) radiation. Data reduction was performed using SAINT software, and structures were solved by direct methods using SHELXS-97.
2.9. Determination of IC50 Values of the Bioactive Compound
Determination of IC50 for antifungal activity of the bioactive compound was done according to the standard M38-A method (NCCLS) with the compound used as the antifungal agent (concentration range 0.04 μg/mL to 10 μg/mL) and amphotericin B as a positive control. Meanwhile, for determination of IC50 value for P388 activity, the same method as in P388 cytotoxicity assay was employed with the bioactive compound tested at concentrations ranging from 1.99 μg/mL to 4.10 μg/mL. Calculation of the IC50 values was based on linear regression of plotted data.
3. Results
3.1. Isolation and Preliminary Screening of Endophytic Fungi
A total of 23 endophytic fungal isolates were isolated from C. mollissimum; 18 isolates were recovered from the leaves and 5 isolates from the plant stem. All fungal isolates were screened for antimicrobial activity. Four of the endophytic fungal isolates inhibited growth of bacteria and/or fungi (Table 1). Of these, only one isolate, CB 007 (WA), inhibited the growth of both bacteria (B. subtilis) and fungi (A. niger and A. fumigatus); therefore, this isolate was selected for further experimentation.
Table 1
Antimicrobial activity of endophytic fungi isolated from C. mollissimum. Target organisms were T01-S. aureus, T02-B. subtilis, T03-E. coli, T04-P. aeruginosa, T05-C. albicans, T06-A. niger, T07-T. viridae, T08-F. Solani, and T09-A. fumigatus (+: inhibition observed and −: no inhibition).
| Endophytic fungal isolates | T01 | T02 | T03 | T04 | T05 | T06 | T07 | T08 | T09 |
|---|---|---|---|---|---|---|---|---|---|
| CB 008 (WA) | − | − | − | − | − | − | − | − | − |
| CL 017 (WA) | − | − | − | − | − | − | − | − | − |
| CL 015 (WA) | − | − | − | − | − | − | − | − | − |
| CL 013 (WA) | − | − | − | − | − | − | − | − | − |
| CL 018 (WA) | − | − | − | − | − | − | − | − | − |
| CL 002 | − | − | − | − | − | − | − | − | − |
| CL 005 | − | − | − | − | − | − | − | − | − |
| CL 019 (WA) | − | − | − | − | − | − | − | − | − |
| CL 008 | − | − | − | − | − | − | − | − | − |
| CL 012 (WA) | − | − | − | − | − | − | − | − | − |
| CL 014 (WA) | − | − | − | − | − | − | − | − | − |
| CL 003 | − | − | − | − | − | − | − | − | − |
| CL 009 | − | − | − | − | − | − | − | − | − |
| CB 002 | − | − | − | − | − | − | − | − | − |
| CB 001 | − | − | − | − | − | − | − | − | − |
| CL 006 | − | − | − | − | − | − | − | − | − |
| CL 010 | − | − | − | − | − | − | − | − | − |
| CB 006 (WA) | − | − | − | − | − | − | − | − | − |
| CL 012 | − | − | − | − | − | − | − | − | − |
| CL 011 | + | − | + | + | − | − | − | − | − |
| CL 007 | + | − | + | + | − | − | − | − | − |
| CB 007 (WA) | − | + | − | − | − | + | − | − | + |
| CL 016 (WA) | − | − | − | − | − | + | − | − | − |
3.2. Biological Activity of CB 007 (WA)
Fractions of CB 007 (WA) crude fungal extract obtained via HPLC were evaluated for antimicrobial and cytotoxic activity. Of 88 fractions tested, three factions were cytotoxic to P388 cells, while 17 fractions inhibited growth of Bacillus subtilis, 8 fractions inhibited growth of Aspergillus fumigates, and 3 fractions inhibited growth of Aspergillus niger. Of these fractions, only one fraction (C7) exhibited antibacterial, antifungal, and cytotoxic activity (Table 2). The UV profile of this fraction indicated the presence of one major compound (result not shown).
Table 2
Biological activity of an HPLC fraction from CB 007 (WA) fungal crude extract. Results are expressed as % of target cells inhibited.
| Assay | Fraction tested | Target cells | Cells inhibited (%) |
|---|---|---|---|
| Antibacterial activity | C7 | B. subtilis | 96.10 |
| Gentamycin (positive control) | B. subtilis | 97.00 | |
| Antifungal activity | C7 | A. niger | 43.10 |
| Amphotericin b (positive control) | A. niger | 96.6 | |
| Cytotoxicity | C7 | P388 murine leukemia cells | 88.60 |
3.3. Identification of the Bioactive Compound
Mass spectrometry, NMR analysis, and crystal structure determination revealed the pure compound in fraction C7 as 5-hydroxyramulosin.
5-Hydroxyramulosin (Figure 1): white crystals; UV (MeOH)
3.4. IC50 Values of the Bioactive Compound
The bioactive compound was also bioassayed to confirm its activity. The pure 5-hydroxyramulosin compound inhibited A. niger and was cytotoxic to P388 murine leukemic cells with IC50 values of 1.56 μg/mL and 2.10 μg/mL, respectively.
4. Discussion
Cinnamomum species is popularly used in herbal medicines due to its various therapeutic properties. Usually, essential oils from the leaf, inner bark, and stems of the plant have been used in herbal preparations [10]. On the other hand, endophytic microorganisms which occur in almost all plants are known to possess pharmacological properties. Therefore, the medicinal properties of a plant may be related to its endophytes. Endophytes from Cinnamomum species have been studied previously [19, 20]. However, there is no study to date on endophytes from C. mollissimum.
In the present study, 23 fungal strains were isolated from C. mollissimum, of which 17.3% (4 isolates) demonstrated antimicrobial activity in preliminary screening. The agar-based screening assay employed is an easy method to identify active isolates for further experimentation and has been recommended as a rapid protocol in natural product research which enables determination of antimicrobial activity when a panel of pathogens are used [21]. One of the isolates, CB 007 (WA), which has not been identified yet but is morphologically similar to a Phoma sp., inhibited the bacteria B. subtilis and pathogenic fungi A. fumigatus and A. niger. As CB 007 (WA) was the isolate with the most broad-ranging activity, it was selected for further investigation to determine its bioactive component.
The approach taken to identify the active compound produced by the fungal isolate CB 007 (WA) was bioassay guided, where fractions of crude fungal extract were evaluated for biological activity prior to purification and structural elucidation of the compound in the active fraction. A microtiter-plate-based assay was employed in this study to test the HPLC fractions of crude fungal extract. This is an effective method to identify highly active fractions, subsequently reducing the time needed to isolate an active compound. The fractions were also evaluated for cytotoxicity against murine leukemic cells in order to select for fractions containing compounds with the most promising activity. As endophytes are known to produce a plethora of secondary metabolites [22], it is very likely that one organism is able to produce several active compounds. The most active fraction (C7) of the fungal extract displayed antibacterial, antifungal, and cytotoxic activity. This activity was consistent with the fungal isolate’s antimicrobial activity in the initial agar plate based screening assay, except the fraction did not inhibit A. fumigatus. Nevertheless, other fractions of the crude extract were active against A. fumigatus (results not shown).
Purification and analysis of the active C7 fraction lead to the structural elucidation of 5-hydroxyramulosin which is a polyketide produced via pentaketide synthase action. Compounds grouped as polyketides are significant in natural product research because of their biosynthetic complexity and value in pharmaceutical industries. The polyketides comprise of toxins, antibiotics, therapeutic compounds, fungal melanins, and other pigments [23]. In fungi, pentaketide synthase is involved in the synthesis of metabolic precursors of melanin [24]. The culture CB 007 (WA) produces melanin when it grows mature (more than 14 days). The production of melanin in a fungus aids its survival especially under stressful conditions and increases its virulence potential [25, 26]. This may explain the biological activity observed in the fungal culture when it was initially screened in agar plate-based assay. Although 5-hydroxyramulosin is a product of pentaketide synthase, it is not known if this compound is involved in melanin synthesis.
Fraction C7 which contained 5-hydroxyramulosin was initially observed to have inhibitory activity against B. subtilis, A. niger, and P388 murine leukemic cells. Nevertheless, when the pure compound 5-hydroxyramulosin was assayed against the same test subjects, inhibition was only detected for A. niger and P388 murine leukemic cells. The fraction may have contained a mixture of compounds, where the inhibitory effect against B. subtilis was due to the presence of other unidentified compound in the fraction. However, when 5-hydroxyramulosin was purified, it was ensured that only this compound was collected manually. 5-Hydroxyramulosin was previously identified in a marine-derived fungus Phoma tropica, and the compound was tested for inhibition of HIV-1 reverse transcriptase enzyme [27].
5. Conclusion
An endophytic fungus isolated from the terrestrial medicinal plant Cinnamomum mollissimum produced 5-hydroxyramulosin, a polyketide compound that had antifungal and cytotoxic activities. This compound may have pharmaceutical potential as it is highly active at low concentrations and is the major bioactive metabolite produced by the fungus.
Conflict of Interests
The authors report no conflict of interests.
[1] R. Maheshwari, "What is an endophytic fungus?," Current Science, vol. 90 no. 10, 2006.
[2] L. Bettucci, M. Saravay, "Endophytic fungi of Eucalyptus globulus : a preliminary study," Mycological Research, vol. 97 no. 6, pp. 679-682, 1993.
[3] S. F. Brady, J. Clardy, "CR377, a new pentaketide antifungal agent isolated from an endophytic fungus," Journal of Natural Products, vol. 63 no. 10, pp. 1447-1448, DOI: 10.1021/np990568p, 2000.
[4] B. Guo, J. R. Dai, S. Ng, Y. Huang, C. Leong, W. Ong, B. K. Carté, "Cytonic acids A and B: novel tridepside inhibitors of hCMV protease from the endophytic fungus Cytonaema species," Journal of Natural Products, vol. 63 no. 5, pp. 602-604, DOI: 10.1021/np990467r, 2000.
[5] B. Zhang, G. Salituro, D. Szalkowski, Z. Li, Y. Zhang, I. Royo, D. Vilella, M. T. Díez, F. Pelaez, C. Ruby, R. L. Kendall, X. Mao, P. Griffin, J. Calaycay, J. R. Zierath, J. V. Heck, R. G. Smith, D. E. Moller, "Discovery of a small molecule insulin mimetic with antidiabetic activity in mice," Science, vol. 284 no. 5416, pp. 974-977, DOI: 10.1126/science.284.5416.974, 1999.
[6] D. Weber, O. Sterner, T. Anke, S. Gorzalczancy, V. Martino, C. Acevedo, "Phomol, a new antiinflammatory metabolite from an endophyte of the medicinal plant Erythrina crista-galli," Journal of Antibiotics, vol. 57 no. 9, pp. 559-563, 2004.
[7] S. Radu, Y. K. Cheah, "Preminary screening of endophytic fungi from medicinal plants in Malaysia for antimicrobial and antitumor activity," Malaysian Journal of Medical Sciences, vol. 9, pp. 23-33, 2002.
[8] I. Jantan, N. Ayop, N. A. M. Ali, A. S. Ahmad, M. F. Yalvema, K. Muhammad, A. R. Azizi, "The essential oils of Cinnamomum rhyncophyllum Miq. as natural sources of benzyl benzoate, safrole and methyl (E)-cinnamate," Flavour and Fragrance Journal, vol. 19 no. 3, pp. 260-262, DOI: 10.1002/ffj.1301, 2004.
[9] J. Heinerman, Encyclopedia of Healing Herbs and Spices, 1966.
[10] A. Chevallier, Encyclopedia of Medicinal Plants, 2001.
[11] I. M. Burgess, Weeds Heal. A Working Herbal, 1998.
[12] D. Frawley, V. Lad, The Yoga of Herbs: An Ayurvedic Guide to Herbal Medicine, 1988.
[13] A. Aguilar, Plantas Medicinales del Centro de Mexico, 1999.
[14] I. B. Jantan, B. A. Karim Moharam, J. Santhanam, J. A. Jamal, "Correlation between chemical composition and antifungal activity of the essential oils of eight Cinnamomum species," Pharmaceutical Biology, vol. 46 no. 6, pp. 406-412, DOI: 10.1080/13880200802055859, 2008.
[15] C. Y. Chen, C. H. Chen, Y. C. Lo, B. N. Wu, H. M. Wang, W. L. Lo, C. M. Yen, R. J. Lin, "Anticancer activity of isoobtusilactone a from Cinnamomum kotoense : involvement of apoptosis, cell-cycle dysregulation, mitochondria regulation, and reactive oxygen species," Journal of Natural Products, vol. 71 no. 6, pp. 933-940, DOI: 10.1021/np070620e, 2008.
[16] G. F. Bills, "Isolation and analysis of endophytic fungal communities from woody plants," Endophytic Fungi in Grasses and Woody Plants, pp. 31-65, 1996.
[17] M. Valan Arasu, V. Duraipandiyan, P. Agastian, S. Ignacimuthu, "In vitro antimicrobial activity of Streptomyces spp. ERI-3 isolated from Western Ghats rock soil (India)," Journal de Mycologie Medicale, vol. 19 no. 1, pp. 22-28, DOI: 10.1016/j.mycmed.2008.12.002, 2009.
[18] G. Lang, M. I. Mitova, G. Ellis, S. Van der Sar, R. K. Phipps, J. W. Blunt, N. J. Cummings, A. L. J. Cole, M. H. G. Munro, "Bioactivity profiling using HPLC/microtiter-plate analysis: application to a New Zealand marine alga-derived fungus, Gliocladium sp," Journal of Natural Products, vol. 69 no. 4, pp. 621-624, DOI: 10.1021/np0504917, 2006.
[19] G. A. Strobel, E. Dirkse, J. Sears, C. Markworth, "Volatile antimicrobials from Muscodor albus , a novel endophytic fungus," Microbiology, vol. 147 no. 11, pp. 2943-2950, 2001.
[20] N. Suwannarach, B. Bussaban, K. D. Hyde, S. Lumyong, "Muscodor cinnamomi, a new endophytic species from Cinnamomum bejolghota," Mycotaxon, vol. 114, pp. 15-23, DOI: 10.5248/114.15, 2010.
[21] P. Cos, A. J. Vlietinck, D. V. Berghe, L. Maes, "Anti-infective potential of natural products: how to develop a stronger in vitro “proof-of-concept”," Journal of Ethnopharmacology, vol. 106 no. 3, pp. 290-302, DOI: 10.1016/j.jep.2006.04.003, 2006.
[22] R. X. Tan, W. X. Zou, "Endophytes: a rich source of functional metabolites," Natural Product Reports, vol. 18 no. 4, pp. 448-459, DOI: 10.1039/b100918o, 2001.
[23] J. S. Tkacz, "Polyketide and peptide products of endophytic fungi: variations on two biosynthethic themes of secondary metabolism," Microbial Endophytes, pp. 265-286, 2002.
[24] H. F. Tsai, I. Fujii, A. Watanabe, M. H. Wheeler, Y. C. Chang, Y. Yasuoka, Y. Ebizuka, K. J. Kwon-Chung, "Pentaketide melanin biosynthesis in Aspergillus fumigatus requires chain-length shortening of a heptaketide precursor," Journal of Biological Chemistry, vol. 276 no. 31, pp. 29292-29298, DOI: 10.1074/jbc.M101998200, 2001.
[25] J. M. Henson, M. J. Butler, A. W. Day, "The dark side of the mycelium: melanins of phytopathogenic fungi," Annual Review of Phytopathology, vol. 37, pp. 447-471, DOI: 10.1146/annurev.phyto.37.1.447, 1999.
[26] T. Lanišnik Rižner, M. H. Wheeler, "Melanin biosynthesis in the fungus Curvularia lunata (teleomorph: Cochliobolus lunatus )," Canadian Journal of Microbiology, vol. 49 no. 2, pp. 110-119, DOI: 10.1139/w03-016, 2003.
[27] C. Osterhage, G. M. König, P. G. Jones, A. D. Wright, "5-hydroxyramulosin, a new natural product produced by Phoma tropica , a marine-derived fungus isolated from the alga Fucus spiralis," Planta Medica, vol. 68 no. 11, pp. 1052-1054, DOI: 10.1055/s-2002-35670, 2002.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright © 2012 Carolina Santiago et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0/
Abstract
An endophytic fungus isolated from the plant Cinnamomum mollissimum was investigated for the bioactivity of its metabolites. The fungus, similar to a Phoma sp., was cultured in potato dextrose broth for two weeks, followed by extraction with ethyl acetate. The crude extract obtained was fractionated by high-performance liquid chromatography. Both crude extract and fractions were assayed for cytotoxicity against P388 murine leukemic cells and inhibition of bacterial and fungal pathogens. The bioactive extract fraction was purified further and characterized by nuclear magnetic resonance, mass spectral and X-ray crystallography analysis. A polyketide compound, 5-hydroxyramulosin, was identified as the constituent of the bioactive fungal extract fraction. This compound inhibited the fungal pathogen Aspergillus niger (IC50 1.56 μg/mL) and was cytotoxic against murine leukemia cells (IC50 2.10 μg/mL). 5-Hydroxyramulosin was the major compound produced by the endophytic fungus. This research suggests that fungal endophytes are a good source of bioactive metabolites which have potential applications in medicine.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Biomedical Science Programme, School of Diagnostic & Applied Health Sciences, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia
2 Department of Chemistry, University of Canterbury, Private Bag 4800, Christchurch 8140, New Zealand
3 Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia